Posizioni attive di Greg Mann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NKARTA, INC. | Contatto Relazioni con gli Investitori | 01/02/2020 | - |
| Public Communications Contact | 01/02/2020 | - |
Storia della carriera di Greg Mann
Precedenti posizioni note di Greg Mann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Contatto Relazioni con gli Investitori | - | 01/01/2006 |
| KITE PHARMA INC | Contatto Relazioni con gli Investitori | 01/01/2016 | - |
| Public Communications Contact | - | - | |
| FIBROGEN, INC. | Contatto Relazioni con gli Investitori | 01/03/2013 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Investor Relations Contact | 4 |
| Public Communications Contact | 2 |
Settori
| Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Greg Mann
- Esperienza
